✦ LIBER ✦

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study

✍ Scribed by Chih-Chiang Chiu; Kuan-Pin Su; Tsung-Chi Cheng; Hsing-Cheng Liu; Ching-Jui Chang; Michael E. Dewey; Robert Stewart; Shih-Yi Huang

Book ID: 116841344
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 450 KB
Volume: 32
Category: Article
ISSN: 0278-5846
DOI: 10.1016/j.pnpbp.2008.05.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Depression in Parkinson's disease: A dou

Depression in Parkinson's disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation

✍ Ticyana Moralez da Silva; Renato Puppi Munhoz; Cristiano Alvarez; Katya Naliwaik 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 296 KB

The effect of low-dose omega 3 fatty aci

The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study

✍ Yaser Tajalizadekhoob; Farshad Sharifi; Hossein Fakhrzadeh; Mojde Mirarefin; Mar 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 272 KB

Effects of n-3 fatty acids on cognitive

Effects of n-3 fatty acids on cognitive decline: A randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients

✍ Johanna M. Geleijnse; Erik J. Giltay; Daan Kromhout 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 935 KB

274 METHYLPHENIDATE FOR THE TREATMENT OF

274 METHYLPHENIDATE FOR THE TREATMENT OF GAIT IMPAIRMENT IN PARKINSON'S DISEASE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY (PRELIMINARY RESULTS)

✍ A. Espay; A. Kumar Dwivedi; J. Vaughan; S. Savage; A. Sahay; A. Duker; F. Revill 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

The effects of rasagiline on cognitive d

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study

✍ Hasmet A. Hanagasi; Hakan Gurvit; Pınar Unsalan; Hilal Horozoglu; Nese Tuncer; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type‐B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the ef

A randomized, double-blind placebo-contr

A randomized, double-blind placebo-controlled trial of simvastatin on CSF, MRI, and cognitive biomarkers in middle-aged adults at risk for Alzheimer's disease: The ESPRIT Study

✍ Cynthia M. Carlsson; Carey E. Gleason; Sterling C. Johnson; Guofan Xu; Yin Huang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 68 KB